TrialTrials2025

A qualitative study exploring participants' experiences of the SCOPE2 trial: chemoradiotherapy dose escalation in oesophageal cancer.

Daniella Holland-Hart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.